ai.design.bio

Decision Intelligence Platform for Biomanufacturing and Sustainable Tech — accelerating investment intelligence with multi-agent decision systems, from diligence to operations.

The Problem

The biomanufacturing and sustainable materials sector faces a critical bottleneck: investors and founders make high-stakes decisions with incomplete information.

Both sides need structured, dynamic frameworks to evaluate technical feasibility, scale-up pathways, and commercial readiness.

The Solution

We’ve developed an AI-agent platform for biomanufacturing investment intelligence — combining strategic simulation with automated due diligence. Multi-agent digital twins simulate operations, validate claims, and benchmark performance across technical, financial, and sustainability dimensions.

Three Core Services

Investment Readiness Assessment

  • Automated technical diligence via agents (manufacturing, materials, bioprocessing, regulation).
  • RAG-enabled validation against literature, patents, FDA/EPA/REACH, ESG standards.
  • Outcome: Standardized risk scoring + scenario-based forecasts.

Scale-Up Viability Analysis

  • Multi-agent simulation from pilot to commercial scale.
  • Role-based agents (Engineer, CFO, Supply Chain) negotiate trade-offs.
  • Stress-tests: feedstock shocks, capex demands, competitive pricing.
  • Outcome: Probability-weighted path-to-profitability.

Real-time Business Monitoring

  • Continuous KPI benchmarking (yield, cost, throughput).
  • Early-warning alerts for bottlenecks, cash burn, regulatory flags.
  • Competitive and demand intelligence.
  • Outcome: Proactive, data-driven portfolio management.

Why This Works

Proven foundations: Validated at Biofabricate’s Biofair (2025) via interactive simulations; tested with 10+ founders.

Technical architecture: Role-specialized agents (Designer, Scientist, Engineer, CFO, Compliance), retrieval-augmented intelligence, evaluation workflows, and sensor-data integration.

Key differentiator: Generic AI summarizes; we simulate decisions — think AlphaGo for biomanufacturing strategy.

Business Model & Market

Revenue: SaaS tiers ($50K–$300K+), per-assessment licensing ($5K–15K), future operational twins ($50K–200K/engagement).

Targets: Biomanufacturing investors (e.g., Breakthrough Energy, Lux, DCVC Bio, DSM Ventures, Superorganism), accelerators (IndieBio, Activate, Greentown Labs), agencies (ARPA-E, DOE, USDA).

Early traction: Prototype piloted with Biofabricate stakeholders; active talks with sustainability-focused investors.

The Ask & Use of Funds

Seed Round: $2.5M to build platform and capture market leadership.

18-month milestones: 12 institutional clients; 150+ assessments; 40% faster diligence; 25% improvement in investment accuracy; first portfolio companies using decision-assistance internally.

Why Now

Founding Team

Orkan Telhan, PhD — Founder, Design.bio

Contact

Email: orkan@design.bio
LinkedIn: linkedin.com/in/orkan-telhan